{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:30:44Z","timestamp":1786595444604,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosacea, a chronic inflammatory skin disorder, affects patients\u2019 physical health. The risk of anxiety disorders in patients with rosacea may be 2\u20133 times higher than that in the general population. However, the key factors influencing anxiety in rosacea remain unclear, and whether alleviating the subjective symptoms of rosacea can further improve treatment outcomes and quality of life requires further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study of 482 newly diagnosed rosacea patients (West China Hospital) was conducted, with grouping into anxiety\/non-anxiety groups for risk factor analysis. After that, a 6-week sub-analysis compared 64 patients receiving conventional carvedilol therapy vs. 32 receiving carvedilol + subjective symptom-targeted treatment, using univariate\/multivariate logistic regression and pre\u2212\/post-treatment symptom\/quality-of-life\/psychological status comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with erythematotelangiectatic rosacea (ETR) had significantly higher Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03). Multivariate analysis revealed that moderate-to-severe burning sensation (odds ratio [OR]\u202f=\u202f1.63), dryness (OR\u202f=\u202f1.90), and pruritus (OR\u202f=\u202f2.76) were independent risk factors for anxiety (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Compared with the conventional group, the targeted group exhibited superior improvements in Investigator\u2019s Global Assessment (IGA) scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.025), Patient Self-Assessment (PSA) scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002), subjective symptoms, HADS-A scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002), and Dermatology Life Quality Index (DLQI) scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.033). patients with erythematotelangiectatic rosacea (ETR) had significantly higher.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Subjective symptoms are independently associated with rosacea-related anxiety. Targeted treatment addressing subjective symptoms is associated with improvements in both overall clinical outcomes and psychological status, highlighting the necessity of systematic assessment and management of subjective symptoms in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1886167","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:24:18Z","timestamp":1786595058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Subjective symptoms are associated with anxiety in patients with rosacea: a cross-sectional study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yuwei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical Spectrum of Rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/jamadermatol.2022.0526","article-title":"Assessment of frequency of Rosacea subtypes in patients with Rosacea: a systematic review and Meta-analysis","volume":"158","author":"Barakji","year":"2022","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s13555-019-00322-5","article-title":"Erythema of Rosacea affects health-related quality of life: results of a survey conducted in collaboration with the National Rosacea Society","volume":"9","author":"Baldwin","year":"2019","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s13555-021-00613-w","article-title":"Depression and anxiety in Rosacea patients: a systematic review and Meta-analysis","volume":"11","author":"Dai","year":"2021","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.abd.2019.03.002","article-title":"Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with Rosacea","volume":"94","author":"Incel Uysal","year":"2019","journal-title":"An Bras Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jad.2021.12.008","article-title":"Association of Rosacea with depression and anxiety: a systematic review and Meta-analysis","volume":"299","author":"Chang","year":"2022","journal-title":"J Affect Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/12034754231204295","article-title":"The mind body connection in dermatologic conditions: a literature review","volume":"27","author":"Mar","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"659171","DOI":"10.3389\/fpsyt.2021.659171","article-title":"Prevalence and risk factors of anxiety and depression in Rosacea patients: a cross-sectional study in China","volume":"12","author":"Chen","year":"2021","journal-title":"Front Psych"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e253796","DOI":"10.1001\/jamadermatol.2025.3796","article-title":"Transcutaneous auricular Vagus nerve stimulation treatment for Erythematotelangiectatic Rosacea: a randomized clinical trial","volume":"161","author":"Li","year":"2025","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of Rosacea: a systematic review and Meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2340\/actadv.v101.356","article-title":"The importance of assessing burning and stinging when managing rosacea: a review","volume":"101","author":"Schaller","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/archdermatol.2010.413","article-title":"Neurogenic Rosacea: a distinct clinical subtype requiring a modified approach to treatment","volume":"147","author":"Scharschmidt","year":"2011","journal-title":"Arch Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5532532","DOI":"10.1155\/drp\/5532532","article-title":"Assessment of depressive and anxiety symptoms and health-related quality of life in Rosacea patients: a case-control study","volume":"2024","author":"Seetan","year":"2024","journal-title":"Dermatol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/ijms26052366","article-title":"Managing a burning face: clinical manifestations and therapeutic approaches for neurogenic Rosacea","volume":"26","author":"Aedo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of Rosacea: the 2017 update by the National Rosacea Society expert committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for Rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/1346-8138.16525","article-title":"Carvedilol ameliorates persistent erythema of Erythematotelangiectatic Rosacea by regulating the status of anxiety\/depression","volume":"49","author":"Li","year":"2022","journal-title":"J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.det.2017.11.005","article-title":"Psychosocial burden and other impacts of Rosacea on patients\u2019 quality of life","volume":"36","author":"Oussedik","year":"2018","journal-title":"Dermatol Clin"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CCID.S126850","article-title":"Psychosocial aspects of Rosacea with a focus on anxiety and depression","volume":"11","author":"Heisig","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/jdv.19913","article-title":"Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi-Centre study","volume":"38","author":"Zeidler","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/09546634.2019.1623368","article-title":"Characterizing high-burden Rosacea subjects: a multivariate risk factor analysis from a global survey","volume":"31","author":"Tan","year":"2020","journal-title":"J Dermatol Treat"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaad.2014.05.036","article-title":"The psychological impact of Rosacea and the influence of current management options","volume":"71","author":"Moustafa","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1886167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:24:19Z","timestamp":1786595059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1886167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":24,"alternative-id":["10.3389\/fpubh.2026.1886167"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1886167","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1886167"}}